Diffuse large B-cell lymphoma with primary retroperitoneal presentation: Clinico-pathologic study of nine cases

Annals of Oncology

Volumn 12, Issue 10, 2001, Pages 1445-1453

  Pileri, S A ^a   Zinzani, P L ^a   Ascani, S ^a   Orcioni, G Fraternali ^a   Gamberi, B ^a   Piccioli, M ^a   Sabattini, E ^a   Poggi, S ^a   Piccaluga, P P ^a   Falini, B ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Clinics; Immunohistochemistry; Large B cell lymphoma; Molecular biology; Retroperitoneum

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD79A ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; HLA DR ANTIGEN; PROTEIN BCL 2; PROTEIN BCL 6;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER REGRESSION; CARCINOGENESIS; CELL COMPARTMENTALIZATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPLASM; DENDRITIC CELL; DERIVATIZATION; DISEASE ASSOCIATION; FEMALE; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDIASTINUM TUMOR; MEDICAL INFORMATION; MICROSCOPY; MORTALITY; PHENOTYPE; PRIORITY JOURNAL; RETROPERITONEUM; SCLEROSIS; TECHNIQUE; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE REARRANGEMENT; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; ONCOGENES; PHENOTYPE; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 0035179370     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012559725243     Document Type: Article

References (57)

1. Malignant lymphoma presenting in the retroperitoneum
2. Sclerosis in non-Hodgkin's lymphomata
3. Retroperitoneal malignant lymphoma showing follicular type: Report of a case
4. Sclerosing variants of follicular center cell lymphomas presenting in the retroperitoneum
5. A revised European-American Classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
6. From the R.E.A.L. Classification to the upcoming WHO scheme: A step forward to a universal categorizing of lymphoma entities?
7. Lymphoma Classification - From controversy to consensus: The R.E.A.L. and WHO Classification of lymphoid neoplasms
8. Diffuse histiocytic lymphoma with sclerosis. A clinicopathologic entity frequently causing superior venacaval obstruction. Cancer clinicopathologic entity frequently causing superior venacaval obstruction
9. Primary non-Hodgkin's lymphoma of the mediastinum
10. Primary large-cell lymphoma of the mediastinum: An analysis of 20 cases
11. Primary mediastinal non-Hodgkin's lymphoma: A morphologic and immunohistologic study of 19 cases
12. Large-cell lymphoma of the mediastinum: A B-cell tumour of probable thymic origin
13. Mediastinal large-cell lymphoma of B-type, with sclerosis: Histopathologic and immunohistochemical study of eight cases
14. Mediastinal diffuse large-cell lymphoma with sclerosis: A clinicopathologic study of 60 cases
15. The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression
16. Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B-cell differentiation
17. Mediastinal large-cell lymphoma with sclerosis. Genotypic analysis establishes its B nature
18. Primary large-cell lymphoma of the mediastinum. A histologic and immunophenotypic study of 29 cases
19. Primary anterior mediastinal B-cell lymphoma: A clinicopathologic and immunohistochemical study of 16 cases
20. Evidence of c-myc gene abnormalities in mediastinal large B-cell lymphoma of young adult age
21. Discordant expression of immunoglobulin and its associated molecule mb-1/CD79a is frequently found in mediastinal large B-cell lymphomas
22. Mediastinal large B-cell lymphoma: Clinical and immunohistochemical findings of 18 patients treated with two different third generation regimens
23. Molecular characterization of primary mediastinal B-cell lymphoma
24. Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: A multicenter study of 106 patients
25. Thymic B-cell non-Hodgkin's lymphoma in a child
26. Mediastinal B-cell lymphoma: A study of its histomorphologic spectrum based on 109 cases
27. Primary mediastinal large B-cell lymphoma: A clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group
28. Primary mediastinal large-cell lymphoma with sclerosis containing a large number of T cells. Differential diagnosis
29. Mediastinal large B-cell lymphoma vs. classic Hodgkin lymphoma
30. Primary mediastinal large B-cell lymphoma with aberrant expression of the β-subunit of human chorionic gonadotropin
31. CD30 expression is common in mediastinal large B-cell lymphoma
32. Primary mediastinal large B-cell lymphoma (PMLBCL): The need for prospective controlled trials
33. 67Gallium scan in 50 patients
34. The MAL gene is expressed in primary mediastinal large B-cell lymphoma
35. Linfomi maligni non-Hodgkin: Dalla tecnica alla diagnostica
36. Histological and immunohistological analysis of human lymphoma
37. Immunohistochemistry of malignant lymphomas. Advantages and limitations of the new monoclonal antibodies working in paraffin sections
38. A rational approach to immunohistochemical analysis of malignant lymphomas on paraffin was sections
39. Antigen retrieval techniques in immunohistochemistry: Comparison of different methods
40. Envision plus: A new immunohistochemical method of choice for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA. LABC, and SABC techniques
41. Impiego dell'ibridazione in situ nello studio dei linfomi a grandi cellule anaplastiche e della malattia di Hodgkin: Differente incidenza di EBER2
42. All advanced stage non-Hodgkin's lymphomas with polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment
43. Immunohistochemical detection of CD10 with monoclonal antibody 56C6 on paraffin sections
44. CD10 antigen expression correlates with the (14: 18)(q32;q21) major breakpoint region in diffuse large B-cell lymphoma
45. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma
46. A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cell
47. Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region
48. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas
49. Mutations of p53 gene and their relation to disease progression in B-cell lymphoma
50. Growth arrest induced by wild-type type p53 protein blocks cells prior to or near the restriction point in late G1 phase
51. P53 mutations and association with resistance to chemotherapy and short survival in hematologic malignancies
52. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma
53. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia
54. CD30 (Ki-1) molecule: A new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy
55. Differential expression of bcl-6, CD138/syndecan-1, and EBV-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas
56. A clinical evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma
57. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling